Abcg4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ABCG4 (ATP-Binding Cassette Subfamily G Member 4) is a member of the ABC transporter G family, also known as the White family. ABCG4 is predominantly expressed in the brain, particularly in neurons and glial cells, where it functions as a cholesterol and phospholipid transporter. This protein plays a critical role in maintaining brain cholesterol homeostasis and has been implicated in Alzheimer's disease pathogenesis through its involvement in amyloid-beta (Aβ) transport across the blood-brain barrier and neuronal cholesterol efflux. ABCG4 forms functional heterodimers with ABCG1 to mediate cholesterol efflux from cells, making it an important regulator of neuronal lipid metabolism.
| Property | Value |
|---|---|
| Protein Name | ABCG4 |
| Gene | ABCG4 |
| UniProt ID | Q9N352 |
| Molecular Weight | ~71 kDa |
| Subcellular Localization | Plasma membrane, endoplasmic reticulum, lipid droplets |
| Protein Family | ABC transporter G family (White family) |
| Tissue Specificity | Brain-specific, high expression in CNS |
| Chromosomal Location | 11q13.2 |
ABCG4 has characteristic ABC transporter structure:
ABCG4 functions exclusively as a heterodimer:
ABCG4 plays essential roles in neuronal cholesterol homeostasis:
ABCG4 is crucial for brain lipid balance:
ABCG4 shows distinctive expression:
ABCG4 is directly implicated in AD pathogenesis:
| Aspect | Role |
|---|---|
| Aβ transport | Mediates Aβ efflux across BBB |
| Cholesterol metabolism | Dysregulation in AD brain |
| Amyloid clearance | Reduced ABCG4 impairs clearance |
| Genetic association | ABCG4 variants linked to AD risk |
| Therapeutic target | Modulating ABCG4 for treatment |
| Approach | Strategy |
|---|---|
| Expression enhancers | Increase ABCG4/ABCG1 expression |
| Cholesterol modulators | Optimize neuronal cholesterol efflux |
| Gene therapy | AAV-mediated ABCG4 delivery |
| Combination therapy | ABCG4 + ABCG1 targeting |
The study of Abcg4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Wang N, et al. (2017). ABCG4: a brain-specific ABC transporter involved in cholesterol homeostasis. J Lipid Res. 58(11):2135-2146. PMID:28924016.
[2] Voss K, et al. (2019). ABCG4 mediates cholesterol efflux from neurons to HDL. J Neurosci. 39(19):3728-3738. PMID:30867255.
[3] Koldamova R, et al. (2021). ATP-binding cassette transporters in Alzheimer disease: therapeutic targets. Nat Rev Neurol. 17(4):201-214. PMID:33723382.
[4] Wahrle SE, et al. (2022). ABCG4 expression decreases with disease progression in Alzheimer's disease brain. Acta Neuropathol. 143(2):153-167. PMID:34807365.
[5] Kim WS, et al. (2018). The role of ABCG4 in amyloid-beta clearance. J Neurochem. 145(5):344-354. PMID:29451362.